Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement

Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195-5066.

A retrospective analysis was undertaken to define the natural history and long-term follow-up of a group of patients with Marfan's syndrome. Eighty-four patients were diagnosed between January 1959 and June 1987 as having Marfan's syndrome; 68% were male; their ages ranged from 2 to 67 years (mean 26.6). Sixteen patients constituted the early surgical group (those who underwent surgery before 1979; mean age 36.1 years). Nineteen patients constituted the late surgical group (surgery in 1979 or later; mean age 33.3 years). The nonsurgical group comprised 49 patients (mean age 19.3 years). Fifty-seven percent of the patients had a diastolic murmur and 38% had cardiomegaly at presentation. Fifty-seven percent underwent cardiac catheterization, which revealed aortic root dilation (85%), aortic regurgitation (73%), aortic dissection (33%) and mitral regurgitation (36%). Thirteen of the 19 patients in the late surgical group received a composite graft repair of the ascending aorta as compared with only 2 of the 16 in the early surgical group. Follow-up information was obtained on 81 (96%) of 84 patients; the follow-up time was 2 to 332 months (mean 99). Thirty-one of the 81 patients died at age 3 to 63 years (mean age 35 years); 87% of the known causes of death were related to the cardiovascular system. Sixty-one percent of deaths were the result of aortic dissection or rupture or sudden cardiac death. Of the 50 survivors, 98%, including all patients in the late surgical group, were in functional class I or II. Overall survival at 5, 10 and 15 years after operation was 78.4%, 57.1% and 49.5%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. R. Brinster, R. J. Rizzo, and R. M. Bolman III Ascending Aortic Aneurysms Card. Surg. Adult, January 1, 2008; 3(2008): 1223 - 1250. [Full Text]

				B. J. Maron, M. J. Ackerman, R. A. Nishimura, R. E. Pyeritz, J. A. Towbin, and J. E. Udelson Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1340 - 1345. [Full Text] [PDF]

				G J Nollen, B E Westerhof, M Groenink, A Osnabrugge, E E van der Wall, and B J M Mulder Aortic pressure-area relation in Marfan patients with and without {beta} blocking agents: a new non-invasive approach Heart, March 1, 2004; 90(3): 314 - 318. [Abstract] [Full Text] [PDF]

				D. Pacini, F. Ranocchi, E. Angeli, F. Settepani, M. Pagliaro, S. Martin-Suarez, R. Di Bartolomeo, and A. Pierangeli Aortic root replacement with composite valve graft Ann. Thorac. Surg., July 1, 2003; 76(1): 90 - 98. [Abstract] [Full Text] [PDF]

				D. A. Danford Marfan Syndrome and Sudden Death AAP Grand Rounds, June 1, 2003; 9(6): 66 - 67. [Full Text] [PDF]

				B. J. Maron, K. P. Carney, H. M. Lever, J. F. Lewis, I. Barac, S. A. Casey, and M. V. Sherrid Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 974 - 980. [Abstract] [Full Text] [PDF]

				C. A. Anderson, R. J. Rizzo, and L. H. Cohn Ascending Aortic Aneurysms Card. Surg. Adult, January 1, 2003; 2(2003): 1123 - 1148. [Full Text]

				R. J. Wityk, C. Zanferrari, and S. Oppenheimer Neurovascular Complications of Marfan Syndrome: A Retrospective, Hospital-Based Study Stroke, March 1, 2002; 33(3): 680 - 684. [Abstract] [Full Text] [PDF]

				C D M van Karnebeek, M S J Naeff, B J M Mulder, R C M Hennekam, and M Offringa Natural history of cardiovascular manifestations in Marfan syndrome Arch. Dis. Child., February 1, 2001; 84(2): 129 - 137. [Abstract] [Full Text]

				C. R. Fikar and S. Koch Etiologic Factors of Acute Aortic Dissection in Children and Younrg Adults Clinical Pediatrics, February 1, 2000; 39(2): 71 - 80. [Abstract] [PDF]

				M Groenink, T A J Lohuis, J G P Tijssen, M S J Naeff, R C M Hennekam, E E van der Wall, and B J M Mulder Survival and complication free survival in Marfan's syndrome: implications of current guidelines Heart, October 1, 1999; 82(4): 499 - 504. [Abstract] [Full Text] [PDF]

				K. Kirali, N. Yakut, M. Guler, D. Mansuroglu, S. Omeroglu, E. Akinci, A. Gurbuz, and C. Yakut Surgical Treatment of Siblings With Marfan Syndrome Asian Cardiovasc Thorac Ann, June 1, 1999; 7(2): 138 - 141. [Abstract] [Full Text] [PDF]

				C. Detter, H. Mair, H.-G. Klein, C. Georgescu, A. Welz, and B. Reichart Long-term prognosis of surgically-treated aortic aneurysms and dissections in patients with and without Marfan syndrome Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 416 - 423. [Abstract] [Full Text] [PDF]

				B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]

				D. W. Glover and B. J. Maron Profile of Preparticipation Cardiovascular Screening for High School Athletes JAMA, June 10, 1998; 279(22): 1817 - 1819. [Abstract] [Full Text] [PDF]

				N. T. Kouchoukos and D. Dougenis Surgery of the Thoracic Aorta N. Engl. J. Med., June 26, 1997; 336(26): 1876 - 1889. [Full Text] [PDF]

				J. C. Mullen, G. Lemermeyer, and M. J. Bentley Recurrent Aortic Dissection After Orthotopic Heart Transplantation Ann. Thorac. Surg., December 1, 1996; 62(6): 1830 - 1831. [Abstract] [Full Text]

				N. T. Kouchoukos Reconstructive Surgery of the Aortic Root Ann. Thorac. Surg., September 1, 1995; 60(3): 734 - 735. [Full Text]

				J. Shores, K. R. Berger, E. A. Murphy, and R. E. Pyeritz Progression of Aortic Dilatation and the Benefit of Long-Term {beta}-Adrenergic Blockade in Marfan's Syndrome N. Engl. J. Med., May 12, 1994; 330(19): 1335 - 1341. [Abstract] [Full Text]